The agreement integrates Klarity’s portfolio into the network facilitated by Clarion, the independent buying arm of ONCare Alliance. By leveraging collective purchasing power, the alliance seeks to reduce equipment costs and provide member practices with enhanced educational resources and technical support. Sean Perkins, co-chair of the Radiation Oncology & Advanced Imaging Work Group at ONCare Alliance, noted that the deal supports operational efficiency while protecting the decision-making authority of individual clinics.

Cheryl S. Turner, Chief Sales Officer at Klarity, emphasized the role of customized immobilization products in advancing standardized care. For Klarity, the partnership represents a strategic expansion of its market reach, while ONCare Alliance continues its broader mission of connecting independent oncologists to share advanced treatment protocols and clinical trials. This move aligns with the network's ongoing efforts to provide community-based providers with the same high-level resources typically reserved for larger hospital systems.